about
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysisAlmanac 2015: atrial fibrillation research in HeartSafety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial dataCardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task forceThe importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trialsRationale and current perspective for early rhythm control therapy in atrial fibrillation.2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theThe ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocolIvabradine in patients with inappropriate sinus tachycardiaSurvivin determines cardiac function by controlling total cardiomyocyte numberPopeye domain containing proteins are essential for stress-mediated modulation of cardiac pacemaking in miceScreening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF)The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry.Brain MRI to personalise atrial fibrillation therapy: current evidence and perspectives.Rate and rhythm control have comparable effects on mortality and stroke in atrial fibrillation but better data are needed.The heart and brain imaging in lone atrial fibrillation - are we surprised?Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.Depressed mood amplifies heart-related symptoms in persistent and paroxysmal atrial fibrillation patients: a longitudinal analysis--data from the German Competence Network on Atrial Fibrillation.Predictors of sinus rhythm after electrical cardioversion of atrial fibrillation: results from a data mining project on the Flec-SL trial data set.Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablationTorsade de pointes induced by ajmaline.Electrophysiologic investigation in Brugada syndrome; yield of programmed ventricular stimulation at two ventricular sites with up to three premature beats.T wave alternans does not assess arrhythmic risk in patients with Brugada syndrome.Pauses after burst pacing provoke afterdepolarizations and torsades de pointes in a patient with long QT syndrome.Electrocardiographic risk stratification in families with congenital long QT syndrome.Prospective, multicentre validation of a simple, patient-operated electrocardiographic system for the detection of arrhythmias and electrocardiographic changes.[Brugada syndrome. Current clinical aspects and risk stratification].Can we improve outcomes in AF patients by early therapy?Routine data from hospital information systems can support patient recruitment for clinical studies.Atrial high-rate episodes and stroke prevention.Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry.PITX2-dependent gene regulation in atrial fibrillation and rhythm control.The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification.Coincidence of paroxysmal supraventricular tachycardia and panic disorder: two case reportsAutonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation.
P50
Q22242892-2D3CF5C8-1E13-4085-BDB0-895E07B73DFFQ26751460-F0318AA0-21EF-4E5F-ACC0-67240FABBC33Q26770598-B9D1ED6D-0CCE-49D1-86F2-EF04A7A83186Q26796271-F8644119-0E5B-4969-AC03-9D848D030D5BQ27006507-AA55399F-AD8A-4B59-A0A1-BEFF723F8BAAQ27009483-1D02C018-B749-4FF9-942B-C30ED20A2407Q27692632-CA62F184-01A0-4117-B310-9AD09C394A62Q28087002-D2F1B1AC-1E63-47DD-B04B-4B7BCEE609F9Q28178857-E75C5E91-1F56-4D81-8FBB-8BB167CCD658Q28293843-248B9EEE-87D9-4180-AD14-51997D269B54Q28580864-86D98623-C77E-46FA-8CFF-72FF6E2F7F59Q28585422-21E7C70C-736E-466B-8208-9704EE241BFCQ30234524-95CFE85C-4AF9-475D-8643-8432CC741212Q30559656-D73B0CCA-34E6-4155-9E4F-9C24AE10D68CQ30647865-8A6EC092-F867-4F53-B33D-22DD0BE32A52Q30663685-85F09372-328F-4873-AD4A-7535DC65F1BBQ30782149-3C8EED68-13BF-4306-BBDD-BA36F8331B1EQ30832547-19B809D4-9380-4C57-A953-F22B23A0A011Q30844226-DF562DE5-2605-4CD7-939E-82999268044FQ30846772-D35A1B54-FFF4-4CD6-AE06-5E99E20D9A12Q30847905-BA265273-4E40-4EB4-ACDE-12AC0FB16E0AQ30919764-7483C9AD-8C0C-4772-8A1F-CCD40CDE3D2DQ31112346-A053B018-21A2-4768-91F6-EB4297D87BB5Q31157420-918BAAFF-55DF-461A-9A79-7E921982B3E8Q33146863-C72E6B32-068C-4615-83A2-1A60DAA122B2Q33148051-E71E73DE-FDFE-4B52-B71F-883EDA8432B7Q33151283-B9B7F639-DFEE-4BEF-A3DC-CA20573CA94EQ33152590-32FAE097-33DA-4F3C-A462-6AB5B45BE17FQ33154118-991182C9-0E3D-46F7-A1DC-9D9673FF1B45Q33157885-EF4C2DF1-C182-451B-A439-2DD01E75CB92Q33163843-0CA1281E-5B8E-4D88-B72B-D069E4E5972BQ33516708-131BD169-48C0-470E-B9E9-7645A966E9D4Q33546278-64BDB01D-87DE-4EEF-BA85-98E4BA710A04Q33589724-1C7EC546-32C9-40FD-8E72-94053B8FC721Q33629421-FF82ADF9-F8EC-47D7-A9C6-865921B9117CQ33800597-65732B8C-4287-4022-A47D-5242D97CD3FCQ33806739-566B9200-65AA-4FBA-AF20-8052EAB88118Q33828623-FF466BC4-A9DA-4810-B57C-EF8340FC0B6FQ33906850-951B860B-6D4A-473E-BE7C-E600980F0FCBQ33939676-AB1E0820-32B4-472D-BF99-F74A264657C2
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Paulus Kirchhof
@ast
Paulus Kirchhof
@en
Paulus Kirchhof
@es
Paulus Kirchhof
@nl
Paulus Kirchhof
@sl
type
label
Paulus Kirchhof
@ast
Paulus Kirchhof
@en
Paulus Kirchhof
@es
Paulus Kirchhof
@nl
Paulus Kirchhof
@sl
prefLabel
Paulus Kirchhof
@ast
Paulus Kirchhof
@en
Paulus Kirchhof
@es
Paulus Kirchhof
@nl
Paulus Kirchhof
@sl
P214
P106
P1153
7004270127
P21
P214
P31
P496
0000-0002-1881-0197
P734
P7859
viaf-45130957